{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:09:39Z","timestamp":1792148979809,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.diagmicrobio.2012.11.009","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T03:04:47Z","timestamp":1357182287000},"page":"115-120","source":"Crossref","is-referenced-by-count":301,"title":["Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes"],"prefix":"10.1016","volume":"75","author":[{"given":"David","family":"van Duin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Neuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0005","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.clinthera.2012.05.002","article-title":"Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort","volume":"34","author":"Alexander","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2011.03478.x","article-title":"Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections","volume":"18","author":"Ben-David","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/11.4.349","article-title":"The pharmacokinetics of temocillin in patients with normal and impaired renal function","volume":"11","author":"Boelaert","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/605922","article-title":"Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"30","author":"Borer","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0025","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1128\/AAC.32.6.938","article-title":"Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults","volume":"32","author":"Borsa","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0030","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0035","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.01420-10","article-title":"Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae","volume":"55","author":"Bulik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0040","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.01402-10","article-title":"Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease","volume":"55","author":"Cai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for Gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-0691.2011.03667.x","article-title":"Colistin pharmacokinetics: the fog is lifting","volume":"18","author":"Couet","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0055","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1469-0691.2011.03553.x","article-title":"Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?","volume":"17","author":"Daikos","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0060","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.00782-08","article-title":"Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections","volume":"53","author":"Daikos","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0065","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/cid\/cis286","article-title":"High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study","volume":"54","author":"Dalfino","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/00365548.2011.616221","article-title":"Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria","volume":"44","author":"Dinh","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0075","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/AAC.01114-09","article-title":"Elucidation of the pharmacokinetic\/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models","volume":"54","author":"Dudhani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0025-6196(11)65134-3","article-title":"The aminoglycosides","volume":"74","author":"Edson","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0085","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/AAC.00556-09","article-title":"ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates","volume":"53","author":"Endimiani","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-5-24","article-title":"Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria","volume":"5","author":"Falagas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0100","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 5","key":"10.1016\/j.diagmicrobio.2012.11.009_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003495-198500295-00034","article-title":"Temocillin concentrations in human tissues","volume":"29","author":"Gould","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0110","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/599225","article-title":"Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center","volume":"48","author":"Hartzell","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0115","first-page":"12","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"12","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0120","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1345\/aph.1H353","article-title":"Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit","volume":"40","author":"Holloway","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0125","doi-asserted-by":"crossref","first-page":"e36649","DOI":"10.1371\/journal.pone.0036649","article-title":"Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs Medical Centers, 2005\u20132010","volume":"7","author":"Huttner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/657138","article-title":"Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes","volume":"31","author":"Hyle","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0135","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2527\/jas.2007-0414","article-title":"Potato (Solanum tuberosum L. cv. Gogu valley) protein as a novel antimicrobial agent in weanling pigs","volume":"86","author":"Jin","year":"2008","journal-title":"J Anim Sci"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/dkr466","article-title":"Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens","volume":"67","author":"Karageorgopoulos","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2012.11.009_bb0145","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ajic.2011.12.014","article-title":"Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and\/or carbapenem-resistant Enterobacteriaceae infections","volume":"40","author":"Ku","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/BF01647220","article-title":"Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges","volume":"15","author":"Kuhnen","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijantimicag.2009.12.002","article-title":"Predictors of acute kidney injury associated with intravenous colistin treatment","volume":"35","author":"Kwon","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/664055","article-title":"Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents","volume":"33","author":"Lautenbach","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-4347(01)00326-7","article-title":"A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography","volume":"761","author":"Li","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0170","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1128\/AAC.46.10.3304-3307.2002","article-title":"Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkh167","article-title":"Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate","volume":"53","author":"Li","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0180","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0190","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/661597","article-title":"Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit medical center","volume":"32","author":"Marchaim","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0195","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dkq070","article-title":"Extracellular concentrations of fosfomycin in lung tissue of septic patients","volume":"65","author":"Matzi","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2005.05.006","article-title":"Pharmacokinetic\/pharmacodynamic profile for tigecycline\u2014a new glycylcycline antimicrobial agent","volume":"52","author":"Meagher","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0205","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0215","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/657135","article-title":"Bloodstream infections caused by metallo-beta-lactamase\/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes","volume":"31","author":"Mouloudi","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","article-title":"Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections","volume":"69","author":"Neuner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0225","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkq116","article-title":"Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation","volume":"65","author":"Nix","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0230","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.47.8.2659-2662.2003","article-title":"Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant Gram-negative bacteria","volume":"47","author":"Ouderkirk","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0235","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jac\/dkq191","article-title":"Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination","volume":"65","author":"Perez","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0240","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0245","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCC.0b013e32834a4b03","article-title":"Trends in antimicrobial resistance in intensive care units in the United States","volume":"17","author":"Prabaker","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0250","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"Prasad","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0255","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens","volume":"56","author":"Qureshi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0260","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.diagmicrobio.2009.08.020","article-title":"Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999\u20132008)","volume":"65","author":"Rhomberg","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0265","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkl403","article-title":"Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose","volume":"58","author":"Rodvold","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0270","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijantimicag.2009.08.013","article-title":"Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections","volume":"34","author":"Roussos","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0275","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-136-11-200206040-00013","article-title":"The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida","volume":"136","author":"Safdar","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0280","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1128\/AAC.00387-11","article-title":"Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine","volume":"55","author":"Satlin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0285","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jac\/dkp230","article-title":"High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection","volume":"64","author":"Schintler","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0290","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/649865","article-title":"An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes","volume":"50","author":"Souli","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.diagmicrobio.2012.11.009_bb0295","first-page":"S397","article-title":"Combating antimicrobial resistance: policy recommendations to save lives","volume":"52","author":"Spellberg","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0300","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/mja11.10724","article-title":"Prevalence of antimicrobial-resistant organisms in residential aged care facilities","volume":"195","author":"Stuart","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0305","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/AAC.49.9.3624-3630.2005","article-title":"Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa","volume":"49","author":"Tam","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0310","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/656289","article-title":"Tigecycline and bacteremia\u2014the dangers of post hoc analysis of pooled data","volume":"51","author":"Tarchini","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0315","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","article-title":"Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis","volume":"11","author":"Tasina","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2012.11.009_bb0320","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by KPC-producing Klebsiella pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0325","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MCC.0b013e32834c9d87","article-title":"Recent trends in antibiotic resistance in European ICUs","volume":"17","author":"van Duijn","year":"2011","journal-title":"Curr Opin Crit Care"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2012.11.009_bb0330","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10096-011-1504-7","article-title":"Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices","volume":"31","author":"Wang","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0335","doi-asserted-by":"crossref","first-page":"U75","DOI":"10.3163\/1536-5050.100.1.018","article-title":"Martindale: the complete drug reference, 37th edition","volume":"100","author":"Wisher","year":"2012","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0340","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/cid\/cir482","article-title":"Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae","volume":"53","author":"Won","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0345","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0350","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00328-11","article-title":"Melatonin attenuates colistin-induced nephrotoxicity in rats","volume":"55","author":"Yousef","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0355","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jac\/dkr483","article-title":"Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics","volume":"67","author":"Yousef","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.11.009_bb0360","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","article-title":"Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment","volume":"17","author":"Zarkotou","year":"2011","journal-title":"Clin Microbiol Infect"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T18:13:05Z","timestamp":1595182385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0732889312004920"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.11.009","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}